Status:
COMPLETED
Study of Cholesterol Levels and Types in African Americans With Type 2 Diabetes
Lead Sponsor:
Mercer University
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Emory University
Conditions:
Type 2 Diabetes
African American
Eligibility:
MALE
18-79 years
Brief Summary
Compared to other races, African-Americans with type 2 diabetes have different cholesterol levels, specifically triglycerides and low density lipoprotein. Recent data has shown the not only are choles...
Eligibility Criteria
Inclusion
- Male
- African American by self-report
- Subjects will be defined as having diabetes if they are diagnosed with diabetes per the American Diabetes Association guidelines
- Subjects without diabetes or impaired glucose tolerance will have a fasting blood glucose \<100 mg/dL and/or glycosylated hemoglobin(A1C) \<6.5%.
Exclusion
- Females
- Self report of race or ethnicity other than African
- Currently taking any lipid-lowering medications
Key Trial Info
Start Date :
December 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2013
Estimated Enrollment :
111 Patients enrolled
Trial Details
Trial ID
NCT01494298
Start Date
December 1 2011
End Date
March 1 2013
Last Update
December 13 2013
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Grady Health System
Atlanta, Georgia, United States, 30303
2
Mercer Univeristy College of Pharmacy and Health Sciences
Atlanta, Georgia, United States, 30341